Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › (S)-hydroxynefazodone antipsychotic therapy

(S)-hydroxynefazodone antipsychotic therapy

US Patent 6586437 · Granted Jul 1, 2003

Estimated economic value: $29,970,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)2022
sGC stimulators2021
Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric sur2020
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-2020
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-2020
sGC stimulators2020
Compositions for colon cleansing and the treatment of gastrointestinal disorders2020
sGC stimulators2019
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-2019
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-2019
Antibody fragments against the insulin receptor and uses thereof to treat hypogl2019
sGC stimulators2019